Track: Stem Cell treatment in Diabetes

Diabetes 2026

Session Overview

This session provides an in-depth overview of stem cell-based therapies and their potential applications in diabetes treatment. It focuses on the biological principles of stem cells, current research progress, and clinical development pathways, while addressing ethical considerations and technical challenges.


Key Topics

Stem Cell Biology and Types: Stem cells are undifferentiated cells capable of self-renewal and differentiation into specialized cell types. This includes embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells.


Beta Cell Regeneration: Research focuses on stimulating the regeneration of insulin-producing beta cells to restore endogenous insulin secretion and improve metabolic control.


Stem Cell-derived Insulin-producing Cells: Advanced differentiation techniques aim to generate functional beta-like cells from stem cells, which can potentially replace damaged pancreatic cells.


Clinical Trials and Translational Research: Clinical trials are evaluating the safety and efficacy of stem cell therapies in diabetes, including transplantation approaches and encapsulation technologies.


Immune Rejection and Safety Concerns: Immune rejection and long-term safety are major challenges, requiring strategies such as immunomodulation, encapsulation, and gene editing to protect transplanted cells.


Learning Objectives

Participants will gain knowledge of stem cell biology and its potential applications in diabetes therapy. The session aims to provide an understanding of current research progress and clinical development pathways. Attendees will be able to evaluate the benefits and challenges of stem cell-based treatments, including safety and ethical considerations. The session also highlights future directions in regenerative medicine and how stem cell therapy could transform diabetes care.